课题基金 / 基金详情

U of Colorado Center for AIDS Research

U of Colorado Center for AIDS Research
科罗拉多大学艾滋病研究中心
批准号:
6604611
负责人:
Robert Turner Schooley
金额:
$150.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-15 至 2008-04-30

项目摘要

项目成果

Robert Turner Schooley的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):这是一份关于建立科罗拉多大学艾滋病研究健康科学中心(Colorado CFAR)的修订申请。拟议中的科罗拉多CFAR是科罗拉多大学健康科学中心及其附属机构的艾滋病毒/艾滋病研究人员的合作成果。科罗拉多大学及其附属机构构成了圣路易斯和加利福尼亚之间唯一的综合性艾滋病研究中心。拟议的CFAR将提供一个独特的综合基础,转化和临床研究与公共卫生和艾滋病预防计划。科罗拉多大学CFAR的目标是通过提供机构基础设施和促进跨学科的科学交流,在艾滋病研究人员之间提供科学领导和刺激科学合作。此外,该基金将促进艾滋病研究方面的培训和教育机会,以及向科学界和整个社会传播知识。为此CFAR提出的特定核心包括发展、临床、病毒学、免疫学和SCID-hu核心。
英文摘要
DESCRIPTION (provided by applicant): This is a revised application to establish the University of Colorado Health Sciences Center for AIDS Research (Colorado CFAR). The proposed Colorado CFAR is a collaborative effort of HIV/AIDS investigators from the University of Colorado Health Sciences Center and its affiliated institutions. The University of Colorado and its affiliated institutions constitute the only comprehensive AIDS research center between St. Louis and California. The proposed CFAR will provide a unique synthesis of basic, translational and clinical research with public health and AIDS prevention programs. The goals of the University of Colorado CFAR are to provide scientific leadership and stimulate scientific collaboration among AIDS investigators by providing institutional infrastructure and promoting scientific communication across disciplines. In addition the CFAR will promote opportunities for training and education in AIDS research, as well as the dissemination of knowledge to the scientific community and to the community at large. Specific cores proposed for this CFAR include Development, Clinical, Virology, Immunology, and SCID-hu cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Sustained-Release Anti-HIV Nucleoside Phosphonate Nanoparticles
Development of Sustained-Release Anti-HIV Nucleoside Phosphonate Nanoparticles
Development of Sustained-Release Anti-coronavirus Nucleoside Phosphonate compounds
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
海外基金